Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 26Pancreatic Neoplasms 11Stomach Neoplasms 10Rectal Neoplasms 10Colonic Neoplasms 10Esophageal Neoplasms 8Adenocarcinoma Of Esophagus 8Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Neoplasms 5Cholangiocarcinoma 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Squamous Cell Carcinoma of Head and Neck 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Carcinoma, Hepatocellular 3Ovarian Neoplasms 2Melanoma 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Carcinoma 2Biliary Tract Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1

Interventions

fludarabine 1dehydroftorafur 1binimetinib 1Specimen Handling 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Fluorouracil 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Klatskin Tumor × Fluorouracil × 30 days × Clear all
NCT05564403 2026-05-13

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
66 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡